Luthra, AZB, Crawford, Platinum, Cravath, Covington advise on Mylan’s $800 million acquisition of Famy Care’s female health bizFebruary 3 2015
US-based generic drugmaker Mylan Inc is acquiring the women's health business of Mumbai-based Famy Care for roughly $800 million (around Rs. 4,950 crore).
The acquisition is being made through its Indian unit, Mylan Laboratories Ltd, for $750 million in cash and an additional $50 million in contingent payments, reports Mint.
Luthra & . . .
You need to have an active subscription to view this content.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports